United States · Industrial & Consumer Products · USD · Annual
Key financials
USD
ROE
61.5%
2025 (actual)
ROA
-248.98%
2025 (actual)
Gross Margin
-
Net Margin
-
Total Assets
$1,263,236.00
2025 (actual)
Net Income
-$2,527,041.00
2025 (actual)
Valuation
-
Stock Price
-
Historical & projected performance
USD
Reported figures and Equlion model projections for the next 4 years.
ROE
-66.3 pt
Company
ROA
+248.7 pt
Company
Total Assets
+0%
Company
Net Income
+99.9%
Company
Detailed data
USD
Key metrics
Amounts in USD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for REGENEREX PHARMA, INC.? It covers the balance sheet, income statement, cash flow and Equlion model projections.